MoonLake Immunotherapeutics (MLTX) Net Income towards Common Stockholders Growth (3y) (2024 - 2026)
MoonLake Immunotherapeutics (MLTX) Net Income towards Common Stockholders Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 84.25% |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -10.84% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 26.38% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -46.86% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 34.98% |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 13.80% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | MoonLake Immunotherapeutics | 1.25 Bn | 888.66 Mn | - | -78.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.68% |
| Dec 31, 2025 | -56.41% |
| Sep 30, 2025 | -68.63% |
| Jun 30, 2025 | -47.64% |
| Mar 31, 2025 | -36.69% |
| Dec 31, 2024 | 4.72% |
| Sep 30, 2024 | -79.08% |
| Jun 30, 2024 | 8.84% |
| Mar 31, 2024 | -467.93% |